A -- NEW THERAPEUTIC TARGETS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE, DIABETES MELLITUS, CONGESTIVE HEART FAILURE, ONCOLOGIC AND IMMUNOLOGIC DISEASE -- SYNTHESIS OF BULK CHEMICALS AND DRUGS FOR PRECLINICAL AND CLINICAL STUDIES

Notice Date

November 7, 2001

Contracting Office

National Institutes of Health, Division of Research Acquisition, OLAO/OA/OD, 6100 Executive Blvd., MSC 7540, Room 6E01, Bethesda, Maryland 20892-7540

ZIP Code

20892-7540

Solicitation Number

260-02-05

Response Due

November 23, 2001

Point of Contact

Jonathan Ferguson, (301) 496-4487

E-Mail Address

click here to contact the Contracting Officer via (jf27t@nih.gov)

Description

The National Institute on Aging (NIA) is seeking small businesses with the capabilities to provide services in the area of synthesis of a variety of medicinal compounds which have been identified in NIA laboratories for development, preclinical toxicology and Phase I, Phase II and Phase III clinical trials. The Full Statement of Work and Technical Evaluation Criteria for this project are located at the following website: http://ocm.od.nih.gov/drc/rfp.htm THIS IS NOT A REQUEST FOR PROPOSAL (RFP) and does not commit the Government to award a contract now or in the future. No RFP is available at this time. Small business concerns that believe they possess the capability necessary to undertake the work described at the above referenced website should submit, to the named Contracting Officer, an electronic copy of their capability statement by 12:00 p.m. on November 23, 2001. The North American Industry Classification System code is 541710. No collect calls will be accepted.****

Web Link

click here to download a copy of the Statement of Work (http://ocm.od.nih.gov/drc/rfp.htm )

Record

Loren Data Corp. 20011109/ASOL011.HTM (W-311 SN512552)